FDA approves groundbreaking sickle cell therapy Casgevy

Lunch and Learn with Dr. Berry

In today's Real Physician Reacts episode, we delve into a groundbreaking development in the treatment of sickle cell disease – the FDA's approval of Casgevy, a revolutionary gene editing therapy. This significant advancement opens new doors for those who have long battled the challenges of sickle cell disease, offering hope and a potential paradigm shift in treatment.

Please SUBSCRIBE for new videos every Monday afternoon and Thursday Evening https://www.drberrypierre.com/YTsubscription​

Let's Connect:

Instagram

TikTok

Lunch and Learn Patreon Family

Key Discussion Points:

• The Plight of Sickle Cell Patients: We’ll explore the struggles faced by individuals with sickle cell disease and the historical context of their treatment.
• Gene Editing Therapy Revolution: Delving into the science behind gene editing therapy, we'll discuss how Casgevy represents a new frontier in medical treatment.
• FDA's Approval of Casgevy: Analyzing the implications of this approval, we'll examine what it means for the future of sickle cell disease management and for patients worldwide.

This episode is an insightful journey into one of the most promising medical advancements of our time, signifying a major step forward in the fight against sickle cell disease.

LINKS:

• FDA Approves 2 Sickle Cell Treatment